Ability of Patients With Low Vision to Properly Instill Eye Drops

Sponsor

Mid-Atlantic Glaucoma Experts (Other)

Overall Status

Completed

CT.gov ID

NCT00760240

Collaborator

(none)

200

Enrollment

Location

Duration (Months)

16.7

Patients Per Site Per Month

Study Details

Study Description

Brief Summary

The investigators are interested in seeing how people with low vision (decreased visual acuity or restricted visual fields) instill eye drops into their own eyes. The investigators hypothesis is that this population will have more difficulty with self-instillation of drops than a better-seeing population. The investigators aim to explore whatever factors may be involved in preventing this population from getting prescribed eyedrops into their eyes, whether it is more related to visual field or visual acuity.

Condition or Disease	Intervention/Treatment	Phase
Glaucoma Retinal Pathology

Detailed Description

This is a study that involves a questionnaire that a study participant fills out, detailing their experience with eyedrops (if any), followed by a video recording of them instilling artificial tears into their worse-seeing eye, with their dominant hand. Patients must have visual acuity worse than 20/60 in at least one eye, and/or have a recent visual field that demonstrated Hodapp criteria for Moderate or Severe visual field damage. This is an observational study of how patients with low vision due to either glaucoma or retinal disease instill eyedrops. Each video will be "graded" by the principal investigator for "success" at instilling eyedrops, and patients will be stratified by their visual acuity or visual field, and whether they have a primary diagnosis of glaucoma or retinal disease.

Study Design

Study Type:

Observational

Anticipated Enrollment :

200 participants

Time Perspective:

Cross-Sectional

Official Title:

Objective Evaluation of the Ability of Patients With Decreased Vision or Restricted Visual Fields to Properly Instill Eye Drops

Study Start Date :

Sep 1, 2008

Actual Primary Completion Date :

Sep 1, 2009

Actual Study Completion Date :

Sep 1, 2009

Arms and Interventions

Arm	Intervention/Treatment
Glaucoma patients This is a group of patients with restricted visual fields or ETDRS visual acuity of 20/60 or worse
Retina patients A group of patients with retinal pathology(ARMD, CME, diabetic retinopathy) contributing to their decreased vision.

Outcome Measures

Primary Outcome Measures

Successful instillation of a single eyedrop onto the surface of the eye [2 minutes]

Eligibility Criteria

Criteria

Ages Eligible for Study:

18 Years and Older

Sexes Eligible for Study:

All

Accepts Healthy Volunteers:

Yes

Inclusion Criteria:

ETDRS visual acuity 20/60 or worse

Exclusion Criteria:

Unwilling to participate
Light perception vision
No light perception vision

Contacts and Locations

Locations

	Site	City	State	Country	Postal Code
1	Glaucoma Specialists/Retina Care Center	Baltimore	Maryland	United States	21209

Sponsors and Collaborators

Mid-Atlantic Glaucoma Experts

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.

Responsible Party:

, ,

ClinicalTrials.gov Identifier:

NCT00760240

Other Study ID Numbers:

SI-08-64

First Posted:

Sep 26, 2008

Last Update Posted:

Apr 26, 2010

Last Verified:

Apr 1, 2010

Keywords provided by , ,

compliance

eyedrop instillation

How patients with low vision due to glaucoma or retinal pathology instill eyedrops into their own eyes.

Additional relevant MeSH terms:

Glaucoma

Study Results

No Results Posted as of Apr 26, 2010